PFIZER INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT05097716
- Locations
- ๐บ๐ธ
New Haven Clinical Research Unit, New Haven, Connecticut, United States
Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to โค49 Years of Age
- Conditions
- RSV
- Interventions
- Biological: RSVpreF (Group 1)Biological: RSVpreF (Group 3)Biological: RSVpreF (Group 2)Biological: Placebo
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1028
- Registration Number
- NCT05096208
- Locations
- ๐บ๐ธ
Precision Clinical Research, Sunrise, Florida, United States
๐บ๐ธVelocity Clinical Research, Providence, East Greenwich, Rhode Island, United States
๐บ๐ธEast-West Medical Research Institute, Honolulu, Hawaii, United States
STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS
- Conditions
- Healthy Adults
- Interventions
- First Posted Date
- 2021-10-26
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 35
- Registration Number
- NCT05093205
- Locations
- ๐บ๐ธ
Anaheim Clinical Trials, LLC, Anaheim, California, United States
MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2021-10-25
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 120
- Registration Number
- NCT05090566
- Locations
- ๐บ๐ธ
Banner Gateway Medical Center, Gilbert, Arizona, United States
๐บ๐ธBanner Gateway Medical Pavilion, Gilbert, Arizona, United States
๐บ๐ธBanner MD Anderson Cancer Center, Gilbert, Arizona, United States
This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT05082428
- Locations
- ๐ซ๐ฎ
Pfizer, Helsinki, Finland
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- First Posted Date
- 2021-10-07
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 61
- Registration Number
- NCT05070845
- Locations
- ๐ต๐ฑ
Pratia Onkologia Katowice, Katowice, Poland
๐บ๐ธEast Carolina University, Greenville, North Carolina, United States
๐ฆ๐บClinical Research Unit Haematology, Division of Cancer Services, St. George Hospital, Kogarah, New South Wales, Australia
Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.
- Conditions
- Ulcerative Colitis
- Interventions
- Other: Stool sample collection
- First Posted Date
- 2021-10-06
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 18
- Registration Number
- NCT05069259
- Locations
- ๐จ๐ญ
Kantonsspital St, Gallen, St. Gallen, Sankt Gallen, Switzerland
๐จ๐ญClarunis, Universitรคtsspital, Basel, Switzerland
๐จ๐ญVerein IBD Study Group, Bern, Switzerland
A Study of PF-07260437 in Advanced or Metastatic Solid Tumors
- Conditions
- Breast NeoplasmsEndometrial NeoplasmsOvarian Neoplasms
- Interventions
- Diagnostic Test: B7-H4 IHC
- First Posted Date
- 2021-10-05
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 30
- Registration Number
- NCT05067972
- Locations
- ๐บ๐ธ
Swedish Cancer Institute, Seattle, Washington, United States
๐บ๐ธUniversity of Washington Medical Center - Mountlake, Seattle, Washington, United States
๐ต๐ทPan American Center for Oncology Trials- Hospital Oncologico, Rio Piedras, Puerto Rico
A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2021-10-05
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 26
- Registration Number
- NCT05067439
- Locations
- ๐บ๐ธ
Research Centers of America ( Hollywood ), Hollywood, Florida, United States
A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC)
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 10
- Registration Number
- NCT05064332
- Locations
- ๐บ๐ธ
Qps-Mra, Llc, South Miami, Florida, United States